ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹44 Cr | ₹46 Cr | ₹44 Cr | ₹49 Cr | ₹59 Cr |
What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹44 Cr |
| Mar2025 | ₹46 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹59 Cr |
How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹44 Cr | -4.76 | |
| Mar2025 | ₹46 Cr | 5.70 | |
| Mar2024 | ₹44 Cr | -10.30 | |
| Mar2023 | ₹49 Cr | -17.87 | |
| Mar2022 | ₹59 Cr | - | |
Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹2,961.3 Cr | 6.5% | -6.9% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 6.5% |
-6.9% |
-16.2% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses